For example, decreased whole-body glucose tolerance may lead to a liver-specific downregulation of hepatic gluconeogenic enzymes, combined with a decrease in hepatic fatty acid oxidation (which provides the energy required to drive gluconeogenesis), as a means to limit hyperglycemia in HFD male GPR19 KO mice. The gene discussed is GPR19; the disease is glucose measurement.